Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 per cent, oxyphenbutazone 10 per cent, and placebo eye ointments.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003315:Cornea / Q000473:pathology; D005128:Eye Diseases / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000008:administration & dosage / Q000627:therapeutic use*; D010146:Pain; D010919:Placebos; D012590:Sclera
D010919:Placebos; D001623:Betamethasone; D010113:Oxyphenbutazone